Biogen (BIIB)
278.88
+3.04 (1.10%)
Upcoming Events
Latest Headlines
Biogen (BIIB) PT Lowered to $352 at Morgan Stanley
January 19, 2021 2:34 AM - StreetInsider
Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone
January 11, 2021 7:30 AM - Globe NewsWire
Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone
January 11, 2021 7:30 AM - StreetInsider
Biogen (BIIB) Climbs 9% Pre-Open, Possibly in Sympathy with Lilly (LLY) Following Alzheimer's Data
January 11, 2021 6:37 AM - StreetInsider
Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases
January 11, 2021 6:00 AM - BizWire
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm
January 8, 2021 9:00 PM - StreetInsider
Biogen (BIIB) Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA in Patients Treated With Zolgensma
January 8, 2021 7:31 AM - StreetInsider
Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec)
January 8, 2021 7:30 AM - Globe NewsWire
Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec)
January 8, 2021 7:30 AM - StreetInsider
SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Files Securities Class Action Lawsuit Against Biogen Inc. on Behalf of Investors Who Acquired Shares from October 22, 2019 to November 6, 2020 and Encourages
January 5, 2021 7:38 PM - StreetInsider
ViGeneron signs global collaboration agreement for ophthalmic gene therapy development
January 5, 2021 2:00 AM - Globe NewsWire
SAGE Therapeutics (SAGE) Receives $875M Upfront Payment from Biogen (BIIB), Sells 6.24M Shares at $104.14
December 31, 2020 4:11 PM - StreetInsider
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Interface, Cabot Oil & Gas, Biogen, and Stride and Encourages Investors to Contact the Firm
December 29, 2020 5:00 PM - StreetInsider
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Stride, JOYY, and Berry Corporation and Encourages Investors to Contact the Firm
December 22, 2020 6:00 PM - StreetInsider
Biogen (BIIB) Announces EC Grants Marketing Authorization for PLEGRIDY Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis
December 21, 2020 7:31 AM - StreetInsider
The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis
December 21, 2020 7:30 AM - Globe NewsWire
The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis
December 21, 2020 7:30 AM - StreetInsider
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cabot Oil & Gas, Biogen, JOYY, and Berry Corporation and Encourages Investors to Contact the Firm
December 16, 2020 7:00 PM - StreetInsider
APRINOIA Therapeutics Established Collaboration on Tau PET Imaging Tracer Development
December 15, 2020 7:00 PM - PR NewsWire
DEADLINE ALERT for BABA, BIIB, YY, LRN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
December 10, 2020 11:30 AM - PR NewsWire
Biogen Files New Drug Application for Aducanumab in Japan
December 9, 2020 10:30 PM - Globe NewsWire
Biogen Files New Drug Application for Aducanumab in Japan
December 9, 2020 10:30 PM - StreetInsider
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cabot Oil & Gas, Biogen, JOYY, and Berry Corporation and Encourages Investors to Contact the Firm
December 9, 2020 8:00 PM - StreetInsider
Form SC 13G/A BIOGEN INC. Filed by: PRIMECAP MANAGEMENT CO/CA/
December 9, 2020 5:01 PM - SEC Filing
Form 4 BIOGEN INC. For: Dec 03 Filed by: Kramer Robin
December 7, 2020 9:09 PM - SEC Filing
Form 4 BIOGEN INC. For: Dec 01 Filed by: Guindo Chirfi
December 3, 2020 5:41 PM - SEC Filing
New Coalition Aims To Close The Opportunity Gap In Bioscience
December 3, 2020 8:00 AM - BizWire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm
December 2, 2020 9:00 PM - StreetInsider
Biogen (BIIB) CEO Buys 3,100 Shares
December 1, 2020 5:10 PM - StreetInsider
Form 4 BIOGEN INC. For: Nov 30 Filed by: Vounatsos Michel
December 1, 2020 4:57 PM - SEC Filing
UPDATE: Biogen (BIIB) PT Raised to $256 at RBC Capital After SAGE Deal Call
December 1, 2020 6:13 AM - StreetInsider
Pre-Open Stock Movers 11/27: (SRNE) (WYY) (APXT) (PLTR) (MARA) (more...)
November 27, 2020 9:05 AM - StreetInsider
Biogen (BIIB) and Sage Therapeutics (SAGE) Announce Pact to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
November 27, 2020 7:31 AM - StreetInsider
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
November 27, 2020 7:30 AM - BizWire
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
November 27, 2020 7:30 AM - Globe NewsWire
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
November 27, 2020 7:30 AM - StreetInsider
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm
November 24, 2020 8:00 PM - StreetInsider
ISD Immunotech, a Novo Seeds Portfolio Company, Enters Strategic Research Collaboration for the Development of a Novel Lupus Treatment
November 23, 2020 4:00 AM - PR NewsWire
Biogen (BIIB) PT Raised to $249 at RBC Capital
November 19, 2020 6:27 AM - StreetInsider
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intercept Pharmaceuticals, Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm
November 18, 2020 9:00 PM - StreetInsider
Samsung Bioepis and Biogen (BIIG) Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis
November 18, 2020 7:02 AM - StreetInsider
Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab)
November 18, 2020 7:00 AM - Globe NewsWire
Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab)
November 18, 2020 7:00 AM - StreetInsider
Buffett's Berkshire Hathaway Enters AbbVie (ABBV), Bristol-Myers (BMY), Merck (MRK), Pfizer (PFE), T-Mobile (TMUS) - 13F
November 16, 2020 4:10 PM - StreetInsider
Biogen Ranked #1 Biotechnology Company by Dow Jones Sustainability World Index for an Industry Record 5th Time; Recognition Reflects Longstanding ESG Leadership
November 16, 2020 7:30 AM - Globe NewsWire
Biogen Ranked #1 Biotechnology Company by Dow Jones Sustainability World Index for an Industry Record 5th Time; Recognition Reflects Longstanding ESG Leadership
November 16, 2020 7:30 AM - StreetInsider
BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm
November 13, 2020 8:00 PM - StreetInsider
BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen, Inc. on Behalf of Biogen Stockholders and Encourages Investors to Contact the Firm
November 12, 2020 8:00 PM - StreetInsider
Increasing unusual put option volume: ERIC ACB REV DHI EWG ABR DDOG BIIB
November 11, 2020 10:18 AM - StreetInsider
Biogen (BIIB) PT Raised to $443 at Truist Securities
November 10, 2020 7:53 AM - StreetInsider
DZ Bank Upgrades Biogen (BIIB) to Buy
November 10, 2020 4:33 AM - StreetInsider
Stocks with Implied Volatility Movement
November 10, 2020 4:20 AM - StreetInsider
Biogen (BIIB) IV comes in, shares down 29% after results of FDA advisory committee voting
November 9, 2020 12:35 PM - StreetInsider
Pre-Open Stock Movers 11/9: (AMC) (CNK) (CCL) Higher; (BIIB) (QDEL) (PTON) Lower (more...)
November 9, 2020 9:32 AM - StreetInsider
Biogen (BIIB) Stock Crashes 30% As FDA Tears Down Alzheimer's Treatment, Prompting Multiple Downgrades
November 9, 2020 8:53 AM - StreetInsider
Biogen plunges 30% after FDA panel votes against Alzheimer's drug
November 9, 2020 8:06 AM - StreetInsider
Energy, travel stocks surge on Pfizer vaccine hopes
November 9, 2020 7:37 AM - StreetInsider
Biogen (BIIB) Resumes Trading, Down 31%
November 9, 2020 7:10 AM - StreetInsider
Biogen (BIIB) to Resume Trading at 7:10 a.m. After FDA Panel's Negative Vote on Potential Treatment for Alzheimer’s Disease
November 9, 2020 6:46 AM - StreetInsider
Biogen (BIIB) Confirms Negative FDA Advisory Committee Votes on Aducanumab in Alzheimer's Disease
November 9, 2020 6:41 AM - StreetInsider
Biogen (BIIB) PT Lowered to $244 at Mizuho Securities
November 9, 2020 6:32 AM - StreetInsider
BofA Securities Downgrades Biogen (BIIB) to Underperform
November 9, 2020 6:18 AM - StreetInsider
Cowen Downgrades Biogen (BIIB) to Market Perform
November 9, 2020 6:18 AM - StreetInsider
Biogen (BIIB) PT Lowered to $338 at Wells Fargo
November 9, 2020 5:50 AM - StreetInsider
Stocks expected to have increasing option volume: BIIB ACB TLRY CRON HEXO
November 9, 2020 5:26 AM - StreetInsider
Biogen (BIIB) IV elevated into results of FDA advisory committee voting
November 9, 2020 4:53 AM - StreetInsider
Biogen (BIIB) IV elevated into results of FDA advisory committee voting
November 9, 2020 4:40 AM - StreetInsider
Biogen (BIIB) PT Lowered to $382 at SVB Leerink
November 9, 2020 4:39 AM - StreetInsider
Atlantic Equities Downgrades Biogen (BIIB) to Underweight
November 9, 2020 3:47 AM - StreetInsider
Form 4 BIOGEN INC. For: Nov 04 Filed by: Sandrock Alfred
November 6, 2020 9:40 PM - SEC Filing
Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease
November 6, 2020 8:15 PM - Globe NewsWire
Biogen (BIIB) IV into FDA panel to discuss Biogen Alzheimer's application and vote
November 6, 2020 7:50 PM - StreetInsider
Biotech ETF (IBB) Lower After Biogen (BIIB) FDA Panel Negative Vote on Question 1
November 6, 2020 3:23 PM - StreetInsider
Biogen (BIIB) Study Fails to Show Alzheimer's Effectiveness, Says FDA Panel
November 6, 2020 3:19 PM - StreetInsider
Biogen (BIIB) Halted, News Pending
November 6, 2020 6:56 AM - StreetInsider
Stocks expected to have increasing option volume: NET UBER BMY ZTS BIIB MTCH
November 6, 2020 4:34 AM - StreetInsider
Biogen (BIIB) option implied volatility elevated after sharp rally into FDA panel
November 5, 2020 10:44 AM - StreetInsider
Increasing unusual put option volume: WMGI BKLN RSX MTCH ZNGA ELAN XME KKR BIIB WEN
November 5, 2020 4:22 AM - StreetInsider
Stocks with Implied Volatility Movement
November 5, 2020 4:15 AM - StreetInsider
Biogen (BIIB) PT Raised to $402 at SVB Leerink
November 5, 2020 4:12 AM - StreetInsider
BofA Securities Upgrades Biogen (BIIB) to Neutral
November 4, 2020 3:15 PM - StreetInsider
Jefferies Upgrades Biogen (BIIB) to Buy
November 4, 2020 1:09 PM - StreetInsider
Biogen (BIIB) Risk/Reward Now Skewed to Downside After Big Move Higher - Mizuho
November 4, 2020 12:50 PM - StreetInsider
Biogen (BIIB) call put ratio 1.7 calls to 1 put with focus as shares rally 39%
November 4, 2020 12:34 PM - StreetInsider
Cowen Said FDA Briefing Docs on Biogen (BIIB) Adu 'Not Without Controversy', Citing Statistical Reviewer
November 4, 2020 11:25 AM - StreetInsider
Biogen (BIIB) Adu Briefing Docs Were Positive, Approval Could Lead to 30-50% Upside - Guggenheim
November 4, 2020 11:11 AM - StreetInsider
Wells Fargo Upgrades Biogen (BIIB) to Overweight
November 4, 2020 11:03 AM - StreetInsider
FDA Giving Biogen (BIIB) Option for Aducanumab Approval on Efficacy from ENGAGE Trial, Shares Worth $443 on Approval - Truist
November 4, 2020 10:54 AM - StreetInsider
AC Immune SA (ACIU) Gains on Biogen Briefing Documents
November 4, 2020 10:21 AM - StreetInsider
Biogen (BIIB) Halted on LUDP
November 4, 2020 10:12 AM - StreetInsider
Biogen (BIIB) Spikes 14% After FDA Posts Briefing Documents for Alzheimer's Drug Aducanumab
November 4, 2020 10:11 AM - StreetInsider
Biogen (BIIB) option implied volatility elevated into FDA panel
November 4, 2020 4:31 AM - StreetInsider
Biogen (BIIB) option implied volatility increases into events
November 3, 2020 11:20 AM - StreetInsider
Biogen (BIIB) to Present Positive Phase 2 Systemic Lupus Erythematosus Data at ACR
November 3, 2020 7:35 AM - StreetInsider
Biogen to Present Positive Phase 2 Systemic Lupus Erythematosus Data at American College of Rheumatology 2020 Meeting
November 3, 2020 7:30 AM - Globe NewsWire
Biogen to Present Positive Phase 2 Systemic Lupus Erythematosus Data at American College of Rheumatology 2020 Meeting
November 3, 2020 7:30 AM - StreetInsider
U.S. experts to review Biogen drug that could be first new Alzheimer's treatment in decades
November 3, 2020 6:20 AM - StreetInsider
Biogen (BIIB) option prices elevated
November 2, 2020 4:22 AM - StreetInsider
Biogen (BIIB) Announces EMA Accepts Aducanumab Marketing Authorization Application for Alzheimer's Disease
October 30, 2020 7:02 AM - StreetInsider
European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer's Disease
October 30, 2020 7:00 AM - Globe NewsWire
European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer's Disease
October 30, 2020 7:00 AM - StreetInsider
Stocks with Implied Volatility Movement
October 30, 2020 4:18 AM - StreetInsider
Stocks with Implied Volatility Movement
October 29, 2020 12:41 AM - StreetInsider
UPDATE: Biogen (BIIB) Initiated at Neutral at UBS
October 27, 2020 4:51 PM - StreetInsider
Biogen (BIIB) Shares Looking 'Interesting' Into Big Week Ahead - Mizuho
October 27, 2020 8:07 AM - StreetInsider
Stocks with Implied Volatility Movement
October 27, 2020 4:29 AM - StreetInsider
Stocks with Implied Volatility Movement
October 23, 2020 4:19 AM - StreetInsider
Biogen (BIIB) PT Raised to $357 at Morgan Stanley
October 22, 2020 8:11 AM - StreetInsider
Biogen (BIIB) PT Lowered to $350 at Credit Suisse
October 22, 2020 5:54 AM - StreetInsider
Biogen (BIIB) PT Lowered to $265 at Barclays
October 22, 2020 5:42 AM - StreetInsider
Stocks with Implied Volatility Movement
October 22, 2020 4:51 AM - StreetInsider
Form 10-Q BIOGEN INC. For: Sep 30
October 21, 2020 5:18 PM - SEC Filing
Biogen (BIIB) PT Lowered to $340 at Oppenheimer
October 21, 2020 4:45 PM - StreetInsider
Biogen (BIIB) PT Lowered to $258 at Stifel
October 21, 2020 4:32 PM - StreetInsider
Biogen (BIIB) PT Lowered to $310 at Truist Securities, Following Earnings
October 21, 2020 3:54 PM - StreetInsider
Form 8-K BIOGEN INC. For: Oct 21
October 21, 2020 7:22 AM - SEC Filing
Biogen (BIIB) Tops Q3 EPS by 71c, Updates Guidance, Approves $5 Billion Buyback
October 21, 2020 7:05 AM - StreetInsider
Full Article List